BLOOD GLUCOSE MONITORING MARKET ANALYSIS

Blood Glucose Monitoring Market, By Type (Self-monitoring blood glucose devices, Continuous glucose monitoring devices, and Flash glucose monitoring devices), By Component (Glucometer devices, Test strips, Lancets, Sensors, and Others), By End User (Hospitals, Homecare Settings, Ambulatory Care Settings, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024
Code : CMI5382
Pages :168
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Blood Glucose Monitoring Market Regional Insights

To learn more about this report, request sample copy

North America remains the dominant region in the global blood glucose monitoring market and is estimated to hold 39.1% of the market share in 2024 owing to the rising incidence of diabetes and growing geriatric population in the region, especially in the U.S. For instance, diabetes is a serious disease, and affects many older adults, as geriatric population is more prone to diabetes. According to the American Diabetes Association, more than 1.5 million people in the U.S. were be diagnosed with diabetes in 2022.

The Asia Pacific region has emerged as the fastest growing market owing to the increasing prevalence of diabetes and increasing demand for blood glucose monitoring devices in the region. For instance, in November 2020, Abbott, a pharmaceutical company, announced the launch of continuous glucose monitoring (CGM) technology, FreeStyle Libre system, in India. The device is now available for adults and children (above the age of four) living with diabetes in India and women with gestational diabetes (diabetes during pregnancy), offering them the choice to check glucose levels anytime and anywhere, ultimately improving glucose control.